Pharma Mar Statistics
Total Valuation
Pharma Mar has a market cap or net worth of EUR 1.27 billion. The enterprise value is 1.19 billion.
| Market Cap | 1.27B |
| Enterprise Value | 1.19B |
Important Dates
The next estimated earnings date is Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
Pharma Mar has 17.21 million shares outstanding.
| Current Share Class | 17.21M |
| Shares Outstanding | 17.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 12.04% |
| Owned by Institutions (%) | 9.24% |
| Float | 13.29M |
Valuation Ratios
The trailing PE ratio is 30.58 and the forward PE ratio is 21.94.
| PE Ratio | 30.58 |
| Forward PE | 21.94 |
| PS Ratio | 6.70 |
| PB Ratio | 6.29 |
| P/TBV Ratio | 6.33 |
| P/FCF Ratio | 714.18 |
| P/OCF Ratio | 144.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.32, with an EV/FCF ratio of 671.00.
| EV / Earnings | 28.37 |
| EV / Sales | 6.30 |
| EV / EBITDA | 31.32 |
| EV / EBIT | 37.90 |
| EV / FCF | 671.00 |
Financial Position
The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.84 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | 28.94 |
| Interest Coverage | 7.69 |
Financial Efficiency
Return on equity (ROE) is 21.94% and return on invested capital (ROIC) is 8.30%.
| Return on Equity (ROE) | 21.94% |
| Return on Assets (ROA) | 5.91% |
| Return on Invested Capital (ROIC) | 8.30% |
| Return on Capital Employed (ROCE) | 12.07% |
| Revenue Per Employee | 378,534 |
| Profits Per Employee | 84,018 |
| Employee Count | 500 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 0.20 |
Taxes
| Income Tax | -9.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.40% in the last 52 weeks. The beta is -0.01, so Pharma Mar's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +0.40% |
| 50-Day Moving Average | 84.77 |
| 200-Day Moving Average | 84.08 |
| Relative Strength Index (RSI) | 28.12 |
| Average Volume (20 Days) | 91,134 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Mar had revenue of EUR 189.27 million and earned 42.01 million in profits. Earnings per share was 2.41.
| Revenue | 189.27M |
| Gross Profit | 179.76M |
| Operating Income | 31.44M |
| Pretax Income | 32.88M |
| Net Income | 42.01M |
| EBITDA | 35.93M |
| EBIT | 31.44M |
| Earnings Per Share (EPS) | 2.41 |
Balance Sheet
The company has 128.08 million in cash and 51.40 million in debt, giving a net cash position of 76.68 million or 4.46 per share.
| Cash & Cash Equivalents | 128.08M |
| Total Debt | 51.40M |
| Net Cash | 76.68M |
| Net Cash Per Share | 4.46 |
| Equity (Book Value) | 201.53M |
| Book Value Per Share | 11.56 |
| Working Capital | 161.62M |
Cash Flow
In the last 12 months, operating cash flow was 8.80 million and capital expenditures -7.02 million, giving a free cash flow of 1.78 million.
| Operating Cash Flow | 8.80M |
| Capital Expenditures | -7.02M |
| Free Cash Flow | 1.78M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 94.98%, with operating and profit margins of 16.61% and 22.20%.
| Gross Margin | 94.98% |
| Operating Margin | 16.61% |
| Pretax Margin | 17.37% |
| Profit Margin | 22.20% |
| EBITDA Margin | 18.98% |
| EBIT Margin | 16.61% |
| FCF Margin | 0.94% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 1.07%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 1.07% |
| Dividend Growth (YoY) | 23.08% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 33.20% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.07% |
| Earnings Yield | 3.31% |
| FCF Yield | 0.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.
| Last Split Date | Jul 22, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0833333333 |
Scores
Pharma Mar has an Altman Z-Score of 7.13 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.13 |
| Piotroski F-Score | 6 |